Published in J Pediatr on January 01, 1994
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada. Can J Infect Dis (2002) 1.20
Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10
Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli. Emerg Infect Dis (1997) 1.03
Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae. Foodborne Pathog Dis (2013) 0.93
Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods. PLoS One (2011) 0.86
Nanolitre real-time PCR detection of bacterial, parasitic, and viral agents from patients with diarrhoea in Nunavut, Canada. Int J Circumpolar Health (2013) 0.85
Risk factors for severe cholera among children under five in rural and urban Bangladesh, 2000-2008: a hospital-based surveillance study. PLoS One (2013) 0.85
Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood. Can J Infect Dis (1995) 0.79
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol (1982) 10.32
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37
Implementation of the Ottawa ankle rules. JAMA (1994) 8.24
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1987) 8.19
The Canadian CT Head Rule for patients with minor head injury. Lancet (2001) 7.91
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA (2001) 7.63
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Statistical power, sample size, and their reporting in randomized controlled trials. JAMA (1994) 6.36
Transmission dynamics and epidemiology of BSE in British cattle. Nature (1996) 6.15
Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63
Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol (1990) 5.41
A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns (1998) 5.40
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
New, extended biotyping scheme for Campylobacter jejuni, Campylobacter coli, and "Campylobacter laridis". J Clin Microbiol (1984) 5.01
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet (1983) 4.70
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet (2001) 4.31
A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med (1987) 4.16
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96
Methodologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med (1999) 3.56
Bovine spongiform encephalopathy: epidemiological studies. Vet Rec (1988) 3.55
A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb Pathog (1988) 3.31
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog (1988) 3.24
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making (1998) 3.18
High-risk STD/HIV behavior among college students. JAMA (1990) 3.14
Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol Infect (1990) 3.02
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis (1986) 2.92
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Variation in emergency department use of cervical spine radiography for alert, stable trauma patients. CMAJ (1997) 2.79
Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1991) 2.78
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol (2000) 2.63
Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis (1996) 2.56
Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. J Pediatr (1991) 2.55
Prospective validation of a decision rule for the use of radiography in acute knee injuries. JAMA (1996) 2.53
What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med (1999) 2.27
Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia (2003) 2.26
Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1999) 2.19
Primary parenteral transmission of bovine spongiform encephalopathy to the pig. Vet Rec (1990) 2.19
Implementation of the Ottawa Knee Rule for the use of radiography in acute knee injuries. JAMA (1997) 2.18
Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98. Vet Rec (2000) 2.17
Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol (1992) 2.11
High-dose epinephrine in adult cardiac arrest. N Engl J Med (1992) 2.06
Differentiation of genes coding for Escherichia coli verotoxin 2 and the verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction. J Clin Microbiol (1990) 2.02
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis (2011) 1.97
Factors influencing the emigration of physicians from Canada to the United States. CMAJ (1996) 1.93
Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet Rec (1991) 1.93
Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol (1992) 1.90
Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child (1970) 1.89
Isolation of verocytotoxin-producing Escherichia coli from milk filters in south-western Ontario. Epidemiol Infect (1989) 1.77
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain (1987) 1.75
Hemorrhagic colitis due to Escherichia coli O157:H7. A rare disease? CMAJ (1986) 1.73
The Ontario Prehospital Advanced Life Support (OPALS) Study: rationale and methodology for cardiac arrest patients. Ann Emerg Med (1998) 1.73
A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect (1993) 1.72
An assessment of clinical wound evaluation scales. Acad Emerg Med (1998) 1.72
Modifiable factors associated with improved cardiac arrest survival in a multicenter basic life support/defibrillation system: OPALS Study Phase I results. Ontario Prehospital Advanced Life Support. Ann Emerg Med (1999) 1.71
Adhesion in vitro and in vivo associated with an adhesive antigen (F41) produced by a K99 mutant of the reference strain Escherichia coli B41. Infect Immun (1982) 1.69
Randomized double-blind controlled trial comparing room-temperature and heated lidocaine for digital nerve block. Ann Emerg Med (1995) 1.68
Sources of salmonellae in an uninfected commercially-processed broiler flock. Can J Comp Med (1980) 1.67
The Canadian CT Head Rule Study for patients with minor head injury: rationale, objectives, and methodology for phase I (derivation). Ann Emerg Med (2001) 1.65
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother (1985) 1.61
Evaluation of renal scars by technetium-labeled dimercaptosuccinic acid scan, intravenous urography, and ultrasonography: a comparative study. J Pediatr (1992) 1.61
A case of accidental inorganic mercury poisoning. J Anal Toxicol (1982) 1.60
Physicians' accuracy and interrator reliability for the diagnosis of unstable meniscal tears in patients having osteoarthritis of the knee. Can J Surg (2001) 1.58
Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise. J Rheumatol (1992) 1.57
Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork, and chicken in southwestern Ontario. Epidemiol Infect (1990) 1.57
Spongiform encephalopathy in an arabian oryx (Oryx leucoryx) and a greater kudu (Tragelaphus strepsiceros) Vet Rec (1990) 1.56
Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr (1997) 1.55
Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature (1988) 1.54
Canadian street youth: correlates of sexual risk-taking activity. Pediatr Infect Dis J (1994) 1.51
Serotyping by slide agglutination of Campylobacter jejuni and epidemiology. Lancet (1981) 1.51
Persistence of Escherichia coli O157:H7 in dairy cattle and the dairy farm environment. Epidemiol Infect (1997) 1.51
CHRIMCY: A proposed institute for research on reproduction, development, and mother, child and youth health. Paediatr Child Health (2000) 1.50
Yersinia enterocolitica infection: report of two cases. Can J Public Health (1973) 1.49
Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J Clin Microbiol (1986) 1.48
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int (2000) 1.48
An assessment of methods to combine published survival curves. Med Decis Making (2000) 1.47
Derivation of a decision rule for the use of radiography in acute knee injuries. Ann Emerg Med (1995) 1.46
Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol Infect (1996) 1.45
Implications of the Canada youth and AIDS study for health care providers. CMAJ (1990) 1.44
Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility. Ann Surg (1997) 1.44
A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis (1995) 1.43